Arch Venture Management’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
Other funds holding PRME
Arch Venture Management's PRME Position: Q3 2026 in Review
Arch Venture Management opened a new position in Prime Medicine (PRME) in Q3 2026: 18,486,894 shares worth $56.5M. The stake represents 3.5% of the portfolio and ranks #12 among its holdings.
181 funds tracked by Wall St. Rank hold PRME as of Q3 2026.
- Arch Venture Management held 18,486,894 shares of Prime Medicine worth $56.5M as of Q3 2026.
- Prime Medicine was a new Arch Venture Management position in Q3 2026.
- Prime Medicine made up 3.5% of Arch Venture Management's portfolio in Q3 2026, its #12 holding.
- 181 funds tracked by Wall St. Rank held Prime Medicine as of Q3 2026.
Based on Arch Venture Management's 13F filing for Q3 2026, filed 16 Nov 2026.